Literature DB >> 1313638

Maintenance itraconazole for visceral leishmaniasis in HIV infection.

A Lafeuillade, P Chaffanjon, E Delbeke, R Quilichini.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1313638     DOI: 10.1016/0002-9343(92)90281-f

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  9 in total

1.  Experimental evaluation of second-line oral treatments of visceral leishmaniasis caused by Leishmania infantum.

Authors:  J P Gangneux; M Dullin; A Sulahian; Y J Garin; F Derouin
Journal:  Antimicrob Agents Chemother       Date:  1999-01       Impact factor: 5.191

2.  Itraconazole as maintenance therapy for visceral leishmaniasis in HIV-infected patients.

Authors:  G Angarano; P Maggi; S L Coppola; R L Cavaliere
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-05       Impact factor: 3.267

3.  Visceral Leishmaniasis treated with antimonials/paromomycin followed by itraconazole/miltefosine after standard therapy failures in a human immunodeficiency virus-infected patient.

Authors:  Patricia Barragán; Rogelio López-Velez; Montserrat Olmo; Daniel Podzamczer
Journal:  Am J Trop Med Hyg       Date:  2010-07       Impact factor: 2.345

Review 4.  Leishmania and human immunodeficiency virus coinfection: the first 10 years.

Authors:  J Alvar; C Cañavate; B Gutiérrez-Solar; M Jiménez; F Laguna; R López-Vélez; R Molina; J Moreno
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

5.  Microscopy and polymerase chain reaction detection of Leishmania chagasi in the pleural and ascitic fluid of a patient with AIDS: Case report and review of diagnosis and therapy of visceral leishmaniasis.

Authors:  Ada Rs Diehl; Rodrigo P Dos Santos; Ricardo Zimmerman; Letícia P Luz; Tanara Weiss; Pedro Jacobson; Luciano Z Goldani
Journal:  Can J Infect Dis Med Microbiol       Date:  2004-07       Impact factor: 2.471

Review 6.  Therapeutic options for visceral leishmaniasis.

Authors:  Begoña Monge-Maillo; Rogelio López-Vélez
Journal:  Drugs       Date:  2013-11       Impact factor: 9.546

Review 7.  Visceral leishmaniasis and HIV coinfection in the Mediterranean region.

Authors:  Begoña Monge-Maillo; Francesca F Norman; Israel Cruz; Jorge Alvar; Rogelio López-Vélez
Journal:  PLoS Negl Trop Dis       Date:  2014-08-21

8.  Atypical presentation of cutaneous leishmaniasis in a renal transplant recipient successfully treated with allopurinol and fluconazole.

Authors:  Soumaya Yaich; Khaled Charfeddine; Abderrahmen Masmoudi; Mondher Masmoudi; Sawssen Zaghdhane; Hamida Turki; Jamil Hachicha
Journal:  Ann Saudi Med       Date:  2012-07-01       Impact factor: 1.526

Review 9.  A screen-and-treat strategy targeting visceral leishmaniasis in HIV-infected individuals in endemic East African countries: the way forward?

Authors:  Johan van Griensven; Ermias Diro; Rogelio Lopez-Velez; Koert Ritmeijer; Marleen Boelaert; Ed E Zijlstra; Asrat Hailu; Lutgarde Lynen
Journal:  PLoS Negl Trop Dis       Date:  2014-08-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.